Rigel Pharmaceuticals
RIGL
#6772
Rank
ยฃ0.60 B
Marketcap
ยฃ32.18
Share price
2.76%
Change (1 day)
8.30%
Change (1 year)

Earnings for Rigel Pharmaceuticals (RIGL)

Earnings in 2026 (TTM): ยฃ95.01 Million

According to Rigel Pharmaceuticals's latest financial reports the company's current earnings are ยฃ0.29 Billion. In 2025 the company made an earning of ยฃ95.26 Million, an increase over its 2024 earnings that were of ยฃ19.38 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rigel Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) ยฃ95.01 M-0.26%
2025 ยฃ95.26 M391.35%
2024 ยฃ19.38 M-244.27%
2023 -ยฃ13.44 Million-66.79%
2022 -ยฃ40.48 Million340.73%
2021 -ยฃ9.19 Million-56.15%
2020 -ยฃ20.95 Million-57.34%
2019 -ยฃ49.1 Million-7.66%
2018 -ยฃ53.17 Million-9.47%
2017 -ยฃ58.73 Million24.46%
2016 -ยฃ47.19 Million23.63%
2015 -ยฃ38.17 Million-43.29%
2014 -ยฃ67.31 Million2.5%
2013 -ยฃ65.67 Million
2010 ยฃ27.92 M-133.97%
2009 -ยฃ82.2 Million-18.49%
2008 -ยฃ0.11 Billion71.91%
2007 -ยฃ58.67 Million84.74%
2006 -ยฃ31.76 Million-10.17%
2005 -ยฃ35.35 Million-15.73%
2004 -ยฃ41.95 Million39.29%
2003 -ยฃ30.12 Million10.3%
2002 -ยฃ27.31 Million48.3%
2001 -ยฃ18.42 Million-2.13%
2000 -ยฃ18.82 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
ยฃ6.70 B 6,951.13%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ10.81 B 11,278.64%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
-ยฃ81.38 Million-185.61%๐Ÿ‡บ๐Ÿ‡ธ USA
ChemoCentryx
CCXI.defunct
-ยฃ96.34 Million-201.34%๐Ÿ‡บ๐Ÿ‡ธ USA